SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years

Inclusion criteria

• ✓. Participant must be ≥12 months to ≤12 years of age, at the time of informed consent.
• ✓. Participant is healthy or medically stable, as determined by the investigator through medical history, physical examination, and overall clinical assessment.
• ✓. Participant's parents/LARs are able and willing to comply with all study procedures and attend all scheduled visits.
• ✓. Female participants of childbearing potential (i.e., post-menarcheal females) must agree to maintain complete sexual abstinence from heterosexual intercourse, from at least 4 weeks prior to the first study vaccination and through 12 weeks following the second study vaccination (Visit 5).
• ✓. Female participants of a childbearing potential must have a negative urine pregnancy test at screening; pregnancy testing is not required for those not of childbearing potential.
• ✓. Participant's parents/LARs are capable of providing signed informed consent, including agreement to comply with the requirements and restrictions specified in this protocol and in the informed consent form (ICF), before initiation of any study-specific procedures. Where applicable, the participant must also be able to provide written assent in accordance with local regulations and IRB/IEC requirements.

Exclusion criteria